Resolving these three limitations would help the clinical application of the examination of tissue-resident CD103+CD8+T cells in HCC or ICC tissues for the prediction of therapeutic efficacy and the understanding of immune regulation mechanism of these two malignancies. The gene discussed is ITGAE; the disease is intrahepatic cholangiocarcinoma.